Cargando…
Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution
BACKGROUND: Lyme disease or Lyme borreliosis (LB) is the commonest vector-borne disease in the North America. It is an inflammatory disease caused by the bacterium Borrelia burgdorferi. The role of the inflammatory processes mediated by prostaglandins (PGs), thromboxanes and leukotrienes (LTs) in LB...
Autores principales: | Jarosz, Alicia Caroline, Badawi, Alaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314976/ https://www.ncbi.nlm.nih.gov/pubmed/30121835 http://dx.doi.org/10.1007/s00011-018-1180-5 |
Ejemplares similares
-
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection
por: Badawi, Alaa
Publicado: (2016) -
Identification of Urine Metabolites as Biomarkers of Early Lyme Disease
por: Pegalajar-Jurado, Adoracion, et al.
Publicado: (2018) -
Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E(2)
por: Sampey, Annaleise V, et al.
Publicado: (2005) -
Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review
por: Badawi, Alaa, et al.
Publicado: (2018) -
Toll-like receptor cascade and gene polymorphism in host–pathogen interaction in Lyme disease
por: Rahman, Shusmita, et al.
Publicado: (2016)